Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Xanodyne Pharmaceuticals Inc.

www.xanodyne.com

Latest From MinInvasive Ltd.

Pacts In Medtech: November/December 2016

Derived from Strategic Transactions, Informa’s premium source for tracking life-sciences deals, this new bimonthly Pacts In Medtech column pulls up notable technology alliances, R&D partnerships and commercial collaborations. This month we highlight deals announced in November and December 2016.

Deals Commercial
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Xanodyne Pharmacal Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Xanodyne Pharmaceuticals Inc.
  • Senior Management
  • Natasha Giordano, Pres. & CEO
    Rita M O'Connor, Chief Financial & Information Officer
  • Contact Info
  • Xanodyne Pharmaceuticals Inc.
    Phone: (859) 371-6383
    1 Riverfront Pl.
    Newport, KY 41071
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register